NNovo Nordisk Read More A Critical Quarter Amid Price Wars and Regulatory Shifts2026-04-12 Novo Nordisk’s Q1 2026 report faces scrutiny over Ozempic/Wegovy price cuts in India and US tariffs, balanced by…
GGreenland Read More European Lithium Shifts Strategy to Greenland Rare Earths Venture2026-04-05 European Lithium pivots from Austrian lithium to Greenland rare earths, launching a share buyback after a 40% concentration…
GGreenland Read More European Lithium Shifts Strategy to Greenland Rare Earths Venture2026-04-05 European Lithium pivots from Austrian lithium to Greenland rare earths, launching a share buyback after a 40% concentration…
ØØrsted Read More Geopolitical Shifts Fuel Optimism for Ørsted’s Offshore Wind Strategy2026-04-04 Geopolitical, Shifts 04.04.2026 – 05:46:45 | boerse-global.de Ørsted shares surge on Bank of America…
ØØrsted Read More Geopolitical Shifts Fuel Optimism for Ørsted’s Offshore Wind Strategy2026-04-04 Geopolitical, Shifts 04.04.2026 – 05:46:45 | boerse-global.de Ørsted shares surge on Bank of America…
AAmsterdam Read More Travel Alerts: Vivid Sydney, Tulip Festival Amsterdam, Flavours of Plenty, Whittaker’s Hotel, Kittawa Lodge Dining2026-03-22 Autumn takes on a more social rhythm in the Coastal Bay of Plenty as the Flavours of Plenty…
NNovo Nordisk Read More Novo Nordisk Faces Swedish Reimbursement Challenge and Shifts US Legal Strategy2026-03-18 Novo Nordisk appeals Sweden’s Wegovy reimbursement denial, withdraws US patent lawsuit. Reports strong 2025 revenue growth but shares…
NNovo Nordisk Read More Shareholder Votes and Strategic Shifts2026-03-15 Novo Nordisk faces key AGM vote and dividend ex-date as shares fall 74% from peak. Strategic moves include…
NNovo Nordisk Read More Novo Nordisk Charts a New Strategic Course Amid Market Shifts2026-03-01 Novo Nordisk cuts Wegovy & Ozempic prices by 50%, partners on $2.1B oral drug deal, and faces a…
NNovo Nordisk Read More Novo Nordisk Shifts Strategy as US Weight-Loss Drug Price War Intensifies2026-02-16 The battle for dominance in the lucrative US market for weight-loss medications is entering a new phase. In…
NNovo Nordisk Read More Regulatory and Legal Shifts Ease Pressure on Novo Nordisk Shares2026-02-11 Novo Nordisk’s position in the crucial GLP-1 drug market received a welcome boost this week, driven by a…
NNovo Nordisk Read More Regulatory and Legal Shifts Ease Pressure on Novo Nordisk Shares2026-02-11 Novo Nordisk’s position in the crucial GLP-1 drug market received a welcome boost this week, driven by a…